Media Advisory
IPI Ideas Author: Misty Woodruff on 01/09/2003
Full Text
Media Advisory (01/21/2003)
Media Advisory (01/09/2003)
Full Text PDF
IPI Expert Available to Discuss Why
Prescription Drug Advertising Is the Solution, Not the Problem.
Prescription Drug Advertising Is the Solution, Not the Problem.
For Immediate Release. Contact: Sonia Hoffman, (703) 912-5742
Dallas, TX. Sunday newspapers bombard readers with advertisements for department stores, office products, cars, clothing, and food. Yet no one is complaining that they can’t afford food because all the grocery stores advertise, or that GM, the number one advertiser in the country, could sell its cars cheaper if the company quit advertising.
Then why is it different for prescription drug advertising?
The critics of direct-to-consumer pharmaceutical advertising claim that 1) it increases drug costs, 2) it increases the dependency upon and use of drugs, 3) giving away free drug samples lures patients into using drugs, and 4) ads encourage patients to demand that doctors give them an advertised drug.
“Virtually all of these criticisms are misleading or wrong,” says IPI Visiting Scholar Dr. Merrill Matthews. “The health care system is changing from a doctor-directed system to a patient-directed one. Patients are hungry for information, and prescription drug ads provide at least some of that information. Ironically, if the critics succeed in limiting or removing these regulated ads, more and more people would be forced to go to the unregulated Internet for health care information.”
Matthews continued, “Prescription drug advertising isn’t the problem, it is the solution.”
- WHO: Merrill Matthews Jr., Ph.D., Visiting Scholar, Institute for Policy Innovation
WHAT: Answering the Critics of Pharmaceutical Advertising Commentary. Addresses Four major
concerns, including: 1) increased drug costs, 2) increased dependency upon and use of
drugs, 3) free drug samples drugs that “lure” patients into using drugs, and 4) patients
demanding that doctors prescribe an advertised drug.
WHEN: Available immediately for TV, radio, print or by phone upon request.
CONTACT: Sonia Hoffman, 703.912.5742 or shoffman@ipi.org
The Institute for Policy Innovation is a free-market economic think tank based in Dallas, Texas. IPI’s focus is on researching and marketing public policy solutions that harness the strength of individual choice,
limited government and pro-growth solutions.
limited government and pro-growth solutions.
